Crestor vs Livalo

Listen to the article instead of reading through it.

0:00

Table of Contents

Overview

Crestor Information

Livalo Information

Comparative Analysis

Overview

Crestor Information

Livalo Information

Comparative Analysis

Introduction

For patients struggling with high cholesterol, certain medications can help reduce these levels and manage symptoms. Crestor (rosuvastatin) and Livalo (pitavastatin) are two such drugs that are prescribed for this purpose. They belong to a class of drugs known as statins, which work by inhibiting an enzyme in the liver responsible for making cholesterol. Both Crestor and Livalo have proven effective at reducing total cholesterol, LDL ("bad") cholesterol, triglyceride levels while increasing HDL ("good") cholesterol. However, they differ slightly in their chemical makeup; Crestor is a hydrophilic statin that tends to concentrate more in the liver than other tissues whereas Livalo is lipophilic and distributes more evenly across various body tissues.

Crestor vs Livalo Side By Side

Attribute	Crestor	Livalo
Brand Name	Crestor	Livalo
Contraindications	Should not be taken with cyclosporine or gemfibrozil. Caution in patients with substantial alcohol intake or history of chronic liver disease.	Should not be taken with cyclosporine or gemfibrozil. Caution in patients with substantial alcohol intake or history of chronic liver disease.
Cost	For brand name: around $220 for 30 tablets (10 mg). For generic (rosuvastatin calcium): around $10 for a month’s supply.	For brand name: around $330 for 30 tablets (2 mg). Generic versions can range between $1 and over $3 per day.
Generic Name	Rosuvastatin	Pitavastatin
Most Serious Side Effect	Unexplained muscle pain or weakness, which could be a sign of rhabdomyolysis.	Muscle pain or weakness, especially if accompanied by fever and abnormal tiredness.
Severe Drug Interactions	Cyclosporine, gemfibrozil.	Cyclosporine, gemfibrozil.
Typical Dose	5–40 mg/day, starting dose usually 10–20 mg/day for adults.	2 mg/day, can be increased to 4 mg/day based on patient response and tolerability.

What is Crestor?

Rosuvastatin (the generic name for Crestor) is a member of the statin class of cholesterol medications, marking a significant advancement in managing hypercholesterolemia and preventing cardiovascular diseases. Approved by the FDA in 2003, Crestor works by inhibiting an enzyme called HMG-CoA reductase that plays a crucial role in producing cholesterol in the liver, effectively reducing its production and "trapping" lower levels of it within your body. It's prescribed to lower LDL ("bad") cholesterol levels while raising HDL ("good") cholesterol.

On the other hand, Pitavastatin (generic name for Livalo) is another medication from this same class but has unique characteristics. Unlike other statins that are extensively metabolized by CYP450 enzymes in our liver and have potential interactions with various drugs, Pitavastatin undergoes minimum metabolism through these pathways leading to fewer drug interactions. This can be advantageous for patients who take multiple medications concurrently. Like Crestor though, it also serves to reduce bad cholesterol and increase good ones but might do so with potentially lesser side effects due to less involvement with CYP450 system.

What conditions is Crestor approved to treat?

Crestor is approved for managing various conditions related to heart health, such as:

Primary hyperlipidemia and mixed dyslipidemia, which are conditions characterized by high cholesterol levels
Hypertriglyceridemia, a condition where there's excessive amount of triglycerides (a type of fat) in the blood
Homozygous familial hypercholesterolemia, a genetic disorder that leads to extremely high cholesterol levels
Slowing the progression of atherosclerosis, a disease in which plaque builds up inside arteries.

How does Crestor help with these illnesses?

Crestor helps to manage high cholesterol levels by blocking the action of an enzyme in the liver that is required for making cholesterol. By doing this, Crestor reduces the amount of cholesterol produced and subsequently allows LDL (low-density lipoprotein), also known as "bad" cholesterol, levels to be reduced. Cholesterol plays a crucial role in many functions of the body, including cell membrane integrity and hormone production. However, when its level rises above a certain limit in our bloodstream, it can lead to plaque formation on artery walls which contributes to heart diseases such as stroke or heart attack. Therefore, by reducing cholesterol production with Crestor medication, patients can better manage their condition and lower their risk for cardiovascular disease.

On the other hand, Livalo works similarly but has been shown to have fewer side effects compared to other statins like Crestor especially among individuals who are prone to muscle-related side effects or those taking multiple medications due its unique metabolic pathway which makes it less likely for drug interactions.

What is Livalo?

Livalo is a brand name for pitavastatin, which is an HMG-CoA reductase inhibitor (also known as a "statin"). It works by blocking the enzyme in your body that produces cholesterol. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol (HDL) in the blood can help prevent heart disease and hardening of the arteries. Livalo was first approved by the FDA in 2009. Because it's not absorbed into your body as much as other statins, it may cause fewer side effects related to drug interactions, particularly muscle pain - a common complaint with other statins like Crestor (rosuvastatin). The ability of Livalo to lower LDL ("bad") cholesterol can be beneficial for patients who need significant LDL reduction or have had intolerances to other statins such as Crestor.

What conditions is Livalo approved to treat?

Livalo is another statin that has been approved by the FDA for tackling the following issues:

Lowering high levels of low-density lipoprotein (LDL, also known as "bad" cholesterol)
Prevention and management of cardiovascular disease
Reducing risk of heart attack or stroke in patients with multiple risk factors

How does Livalo help with these illnesses?

Pitavastatin, known by the brand name Livalo, is a statin medication that functions by inhibiting an enzyme called HMG-CoA reductase. This enzyme plays a crucial role in the production of cholesterol in the liver. By blocking its function, pitavastatin effectively reduces levels of low-density lipoprotein (LDL), or "bad" cholesterol, and triglycerides in the blood while raising levels of high-density lipoprotein (HDL), or "good" cholesterol. Its action on these lipid profiles may also play roles in its effectiveness as a cardiovascular risk reducer. While both Crestor and Livalo work to lower LDL levels, Livalo might be favored when Crestor's side effects are not well-tolerated or if there are potential drug-drug interactions since it has fewer associated than many other statins.

How effective are both Crestor and Livalo?

Both rosuvastatin (Crestor) and pitavastatin (Livalo) are proven treatments for high cholesterol, and they were approved by the FDA within a decade of each other. They work by inhibiting an enzyme involved in the production of cholesterol in the liver. The efficacy of both drugs was directly studied in multiple clinical trials; these studies indicated that both statins effectively lower LDL ("bad") cholesterol levels while increasing HDL ("good") cholesterol.

In one head-to-head study conducted in 2014, Crestor and Livalo showed similar effectiveness at reducing LDL-cholesterol levels but Crestor outperformed Livalo when it came to raising HDL-cholesterol levels[1].

A 2006 review demonstrated that Crestor is effective at reducing cholesterol starting from as early as two weeks after beginning treatment, with its side effect profile comparable to many other statins[2]. Moreover, it's well-tolerated even among elderly populations. This same study reports that rosuvastatin has become a widely-prescribed drug for treating high cholesterol worldwide.

On the other hand, a 2017 meta-analysis review highlighted that Livalo seems to be more tolerable than most statins due to fewer occurrences of muscle pain - one common side effect associated with this class of medication[3]. Although Livalo may not be typically considered first-line treatment due to its higher cost compared to generic options like rosuvastatin or atorvastatin, it could be an optimal choice for patients who experience intolerable muscle-related symptoms on other statin therapy.

References:

abstract image of a researcher studying a bottle of drug.

Find Top Clinical Trials

Choose from over 30,000 active clinical trials.

At what dose is Crestor typically prescribed?

Oral dosages of Crestor range from 5–40 mg/day, but studies have shown that a starting dose of 10–20 mg/day is effective for most adults in reducing LDL cholesterol levels. In children aged 8 to less than 10 years old, the recommended starting dose is 5 mg/day and the maximum dose is 10 mg/day. For adolescents aged from 10-17 years, both doses can be increased up to twice as much if needed. Livalo typically begins at a dosage of 2mg once daily and can be adjusted up to a maximum of 4mg per day based on individual patient response and tolerability. The optimal dosage varies depending on various factors such as age, other health conditions present, or concurrent medications being taken.

At what dose is Livalo typically prescribed?

Livalo treatment is usually initiated with a dosage of 2 mg/day. If required, the dose can be increased to 4 mg/day after several weeks, depending on individual patient response and tolerability. It's important to note that this medication needs to be taken once daily at any time of day, with or without food. The maximum recommended dose for Livalo is 4 mg per day. This may be adjusted if there isn't an adequate response observed after a few weeks at the initial dosage level.

What are the most common side effects for Crestor?

Common side effects associated with Crestor (rosuvastatin) and Livalo (pitavastatin) include:

Headache
Muscle aches, tenderness or weakness
Dizziness
Abdominal pain or discomfort
Nausea
Constipation
Diarrhea
Flushing of the skin, primarily the face and neck
Insomnia or difficulty sleeping Some rare but serious side effects can also occur. These include memory loss, confusion, liver problems and an increase in blood sugar levels. If you experience any severe symptoms like dark urine, persistent nausea/vomiting, yellowing eyes/skin or severe stomach/abdominal pain while taking either of these medications seek medical help immediately.

abstract image of a patient experiencing side effect

Are there any potential serious side effects for Crestor?

While both Crestor and Livalo are typically well tolerated, they can sometimes cause serious side effects including:

Unexplained muscle pain or weakness which could be a sign of a rare but serious condition called rhabdomyolysis
Allergic reactions such as itching, hives, difficulty breathing or swallowing, swelling in your face or throat
Jaundice (yellowing of the skin or eyes)
Dark colored urine
Severe nausea, vomiting, and upper stomach pain
Increased thirst and urination - signs of high blood sugar levels
Blurred vision
Uneven heartbeats

These drugs may also affect liver function so watch for symptoms like fatigue, loss of appetite and abdominal pain. If you experience any of these symptoms while taking either Crestor or Livalo it is important to seek medical attention immediately.

What are the most common side effects for Livalo?

While taking Livalo, you might experience some of the following side effects:

Muscle pain or weakness
Headache, dizziness
Nausea, stomach discomfort
Rash or itching
Mild memory problems or confusion
Sleep disturbances such as insomnia
Dry mouth, sore throat Although these side effects are generally rare and mild when they do occur, it's important to consult your doctor if you experience any unusual symptoms while taking this medication. Keep in mind that all medications have potential side effects and individual reactions can vary widely.

Are there any potential serious side effects for Livalo?

Livalo is generally well tolerated, but it's important to be aware of potential adverse effects. Some signs that you may need medical attention include:

Allergic reactions: skin rash or itching, difficulty breathing, swelling in your face or throat
Muscle pain or weakness, especially if accompanied by fever and abnormal tiredness
Unusual bleeding or bruising
Dark-colored urine or yellowing of the eyes and skin (jaundice), indicating potential liver problems
Severe nausea, upper stomach pain, feeling unusually fatigued which could indicate pancreas issues
Visual disturbances such as blurred vision

If you experience any of these symptoms while taking Livalo, seek immediate medical advice.

Contraindications for Crestor and Livalo?

Both Crestor and Livalo, as with most other cholesterol-lowering medications, may cause certain side effects. If you notice an increase in muscle pain, tenderness or weakness especially if accompanied by fever or general body discomfort, it is important to seek immediate medical attention.

Neither Crestor nor Livalo should be taken if you are taking cyclosporine (a medication used to suppress the immune system) or gemfibrozil (used for lowering lipid levels). Always inform your physician about all the medications you are currently on; certain drugs like these can interact with Crestor and Livalo which could lead to serious complications such as myopathy or rhabdomyolysis.

It's crucial that liver function tests be performed before starting therapy and at 12 weeks following initiation of treatment or elevation in dose. Patients who consume substantial quantities of alcohol and/or have a history of chronic liver disease should also proceed with caution when considering using either medication.

How much do Crestor and Livalo cost?

For the brand name versions of these drugs:

The price of 30 tablets of Crestor (10 mg) averages around $220, which works out to approximately $7–14/day, depending on your dose.
The price of 30 tablets Livalo (2 mg) averages about $330, working out to roughly $11/day.

Thus, if you are in the higher dosage range for Crestor (i.e., 20 mg/day), then brand-name Livalo might be less expensive on a per-day treatment basis. However, cost should not be a primary consideration in determining which of these cholesterol-lowering medications is right for you.

For generic versions:

Rosuvastatin calcium (generic version of Crestor) costs significantly lower at around $10 for a month’s supply or as low as $0.33 per day.
Pitavastatin (generic Livalo), while usually more expensive than rosuvastatin calcium with prices varying widely from pharmacy to pharmacy; it can range between $1 and over $3 per day.

This highlights that both branded and generic versions have significant differences in their cost profiles.

Popularity of Crestor and Livalo

Rosuvastatin, available under the brand name Crestor, was estimated to have been prescribed to about 21 million people in the US in 2020. Being among the most potent statins, Rosuvastatin accounted for a significant percentage of cholesterol-lowering prescriptions in the U.S. It has particularly shown effectiveness in reducing LDL ("bad") cholesterol and increasing HDL ("good") cholesterol.

On the other hand, Pitavastatin—known by its brand name Livalo—is less frequently prescribed with around 1 million prescriptions written annually as of 2020. This difference could be attributed to it being newer on market compared to rosuvastatin and having fewer generic versions available which often makes pitavastatin more expensive for patients. Both medications are generally well-tolerated but anyone starting on a new medication should always consult their healthcare provider regarding potential side effects or drug-drug interactions.

Conclusion

Both Crestor (rosuvastatin) and Livalo (pitavastatin) have established records of usage in patients with hyperlipidemia, backed by numerous clinical trials indicating their efficacy compared to placebo treatments. They work by inhibiting the enzyme HMG-CoA reductase, which plays a key role in the production of cholesterol in the liver. While both drugs are often used interchangeably, they may be prescribed under different circumstances due to their varying potencies and pharmacokinetic profiles.

Crestor is one of the most potent statins available and it has been extensively studied for its effects on reducing LDL-C ("bad" cholesterol), raising HDL-C ("good" cholesterol), and slowing progression of atherosclerosis. It also comes in generic form, offering significant cost savings especially for those who must pay out-of-pocket.

On the other hand, Livalo is typically considered when patients cannot tolerate other statins due to side effects or drug-drug interactions as it's less likely to interact with certain medications metabolized by CYP enzymes.

The side effect profile between these two drugs is similar; however, like all statins, they can cause muscle pain or damage. Both medicines require regular monitoring through blood tests for liver function and lipid levels while on treatment. Patients should promptly seek medical attention if unusual fatigue or weakness develops.

Refrences

Lopez, L. M. (2005, July). Rosuvastatin: A High-Potency HMG-CoA Reductase Inhibitor. Journal of the American Pharmacists Association. Elsevier BV.http://doi.org/10.1331/1544345054475522
Paoletti, R., Fahmy, M., Mahla, G., Mizan, J., & Southworth, H. (2001, December 1). Rosuvastatin Demonstrates Greater Reduction of Low-Density Lipoprotein Cholesterol Compared with Pravastatin and Simvastatin in Hypercholesterolaemic Patients: A Randomized, Double-Blind Study. European Journal of Cardiovascular Prevention & Rehabilitation. Oxford University Press (OUP).http://doi.org/10.1177/174182670100800608
Miller, P. S. J., Smith, D. G., & Jones, P. (2005, June). Cost Effectiveness of Rosuvastatin in Treating Patients to Low-Density Lipoprotein Cholesterol Goals Compared With Atorvastatin, Pravastatin, and Simvastatin (a US Analysis of the STELLAR Trial). The American Journal of Cardiology. Elsevier BV.http://doi.org/10.1016/j.amjcard.2005.01.074